TIDMMDC
RNS Number : 6105G
Mediclinic International plc
24 July 2019
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", or the "Company" or the "Group")
24 July 2019
DIRECTORATE CHANGES
APPOINTMENT OF TOM SINGER AS AN INDEPENDENT NON-EXECUTIVE
DIRECTOR
Mediclinic announces that Tom Singer is to join its Board as an
independent non-executive director with effect from 24 July
2019.
Dr Edwin Hertzog, Chairman of Mediclinic, commented:
"The Board is delighted to welcome Tom Singer as an independent
non-executive director of the Company. His financial acumen and
expertise in UK listed international hospitality and branded
consumer businesses will be valuable additions to the Board's
existing skillset."
Tom has extensive board experience and expertise in
international branded consumer businesses and a thorough
understanding of the UK listed environment. He has served as Chief
Financial Officer of InterContinental Hotels Group PLC, a leading
international hotel group, and British United Provident Association
(BUPA), a provider of health insurance, care homes for the elderly
and other health related services including private hospitals.
Earlier in his career, Tom was Chief Financial Officer and Chief
Operating Officer of William Hill PLC and Finance Director of Moss
Bros PLC, having started his career in professional services
spending a total of 12 years at Price Waterhouse and McKinsey. He
currently serves as a non-executive director on the boards of DP
Eurasia N.V., an operator of pizza restaurants in Turkey and
Russia, and Liberty Living Group PLC, a provider of student
accommodation in the UK.
Tom holds a degree in Economics and Accounting (University of
Bristol), is a Chartered Accountant and has attended the Advanced
Management Programme at INSEAD.
There are no disclosures required pursuant to paragraphs (1) to
(6) of LR 9.6.13 R of the UK Listing Authority's Listing Rules in
respect of this appointment. Tom Singer's fees will amount to GBP73
000 per annum, including the fee payable for membership of the
Audit and Risk Committee as referred to below, which is in line
with current independent non-executive directors.
CHANGES TO COMMITTEE MEMBERSHIPS
The Board also agreed to certain other changes to the membership
of its committees. As announced on 15 November 2018, Desmond Smith,
the Company's Senior Independent Director, will be retiring as a
director of the Company upon the conclusion of the Company's Annual
General Meeting being held today, at which point his memberships of
all Board committees will cease. Alan Grieve will succeed Desmond
Smith as Senior Independent Director of the Company and as Chairman
of the Audit and Risk Committee. The Company also confirms the
following Board committee changes:
Audit and Risk Committee:
With effect from 24 July 2019, Desmond Smith will step down as a
member and Chairman of the Audit and Risk Committee. Alan Grieve
will succeed Desmond Smith as Chairman of this Committee and Tom
Singer will become a member of this committee from that date.
Nomination Committee:
With effect from 24 July 2019, Desmond Smith will step down as a
member of the Nomination Committee and will be succeeded on that
committee by Alan Grieve.
About Mediclinic International plc
Mediclinic is an international private healthcare services
group, established in South Africa in 1983, with divisions in
Switzerland, Southern Africa (South Africa and Namibia) and the
United Arab Emirates.
The Group's core purpose is to enhance the quality of life by
way of appropriate healthcare services.
Mediclinic is focused on providing specialist-orientated,
multi-disciplinary services across the continuum of care in such a
way that the Group will be regarded as the most respected and
trusted provider of healthcare services by patients, medical
practitioners, funders and regulators of healthcare in each of its
markets.
Mediclinic comprises 77 hospitals, five sub-acute hospitals, 13
day case clinics and 21 outpatient clinics. Hirslanden operates 18
hospitals, two day case clinics and three outpatient clinics in
Switzerland with more than 1 900 inpatient beds; Mediclinic
Southern Africa operates 52 hospitals, five sub-acute hospitals and
9 day case clinics with more than 8 500 inpatient beds; and
Mediclinic Middle East operates seven hospitals, two day case
clinics and 21 outpatient clinics with more than 900 inpatient beds
in the United Arab Emirates.
The Company's primary listing is on the London Stock Exchange
("LSE") in the United Kingdom, with secondary listings on the JSE
Ltd in South Africa and the Namibian Stock Exchange in Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a leading private healthcare group based in the United Kingdom
and listed on the LSE.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6(th) Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International
plc and UBS Investment Bank
JSE Ltd sponsor: Rand Merchant Bank (A division of FirstRand
Bank Ltd)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAPGUPCMUPBGWC
(END) Dow Jones Newswires
July 24, 2019 09:50 ET (13:50 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024